X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DISHMAN PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DISHMAN PHARMA ABBOTT INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 36.5 25.1 145.6% View Chart
P/BV x 10.6 3.3 315.8% View Chart
Dividend Yield % 0.6 0.7 87.3%  

Financials

 ABBOTT INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
DISHMAN PHARMA
Mar-16
ABBOTT INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs5,190374 1,386.2%   
Low Rs4,351129 3,375.5%   
Sales per share (Unadj.) Rs1,382.9197.8 699.1%  
Earnings per share (Unadj.) Rs130.221.2 613.9%  
Cash flow per share (Unadj.) Rs137.934.7 397.2%  
Dividends per share (Unadj.) Rs40.002.00 2,000.0%  
Dividend yield (eoy) %0.80.8 105.5%  
Book value per share (Unadj.) Rs652.7179.9 362.8%  
Shares outstanding (eoy) m21.2580.69 26.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.3 271.1%   
Avg P/E ratio x36.611.9 308.8%  
P/CF ratio (eoy) x34.67.2 477.2%  
Price / Book Value ratio x7.31.4 522.5%  
Dividend payout %30.79.4 325.8%   
Avg Mkt Cap Rs m101,37320,306 499.2%   
No. of employees `0003.10.8 371.9%   
Total wages/salary Rs m3,4535,355 64.5%   
Avg. sales/employee Rs Th9,531.919,252.7 49.5%   
Avg. wages/employee Rs Th1,119.96,459.5 17.3%   
Avg. net profit/employee Rs Th897.32,064.1 43.5%   
INCOME DATA
Net Sales Rs m29,38715,961 184.1%  
Other income Rs m576265 217.2%   
Total revenues Rs m29,96316,226 184.7%   
Gross profit Rs m3,9734,103 96.8%  
Depreciation Rs m1641,091 15.1%   
Interest Rs m20944 2.2%   
Profit before tax Rs m4,3652,334 187.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,598624 256.3%   
Profit after tax Rs m2,7671,711 161.7%  
Gross profit margin %13.525.7 52.6%  
Effective tax rate %36.626.7 137.0%   
Net profit margin %9.410.7 87.8%  
BALANCE SHEET DATA
Current assets Rs m18,90611,018 171.6%   
Current liabilities Rs m6,2979,517 66.2%   
Net working cap to sales %42.99.4 456.3%  
Current ratio x3.01.2 259.4%  
Inventory Days Days62110 56.3%  
Debtors Days Days2235 62.1%  
Net fixed assets Rs m1,15916,304 7.1%   
Share capital Rs m213161 131.7%   
"Free" reserves Rs m13,65712,907 105.8%   
Net worth Rs m13,86914,516 95.5%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m20,63829,805 69.2%  
Interest coverage x215.03.5 6,193.2%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.40.5 265.9%   
Return on assets %13.58.9 151.6%  
Return on equity %19.911.8 169.2%  
Return on capital %31.617.5 180.4%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m04,952 0.0%   
Fx outflow Rs m0697 0.0%   
Net fx Rs m04,255 0.0%   
CASH FLOW
From Operations Rs m3,0722,786 110.3%  
From Investments Rs m-1,554-1,529 101.6%  
From Financial Activity Rs m-898-941 95.4%  
Net Cashflow Rs m621316 196.1%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 22.1 77.4%  
Shareholders   18,270 46,261 39.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Drops 230 Points as Trade War Fears Resurface(12:30 pm)

After opening the day flat, share markets in India witnessed choppy trading activity throughout the day and are presently below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 19, 2018 02:15 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS